Search

Your search keyword '"Muthusamy, R"' showing total 262 results

Search Constraints

Start Over You searched for: Author "Muthusamy, R" Remove constraint Author: "Muthusamy, R"
262 results on '"Muthusamy, R"'

Search Results

2. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

3. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

6. Contributors

8. Racemic Guaifenesin Preparation by in vivo Williamson ether synthesis and FTIR, NMR, HPLC and GCMS spectral analysis

10. OC.14.1 MULTICENTER RETROSPECTIVE INTERNATIONAL STUDY TO EVALUATE OUTCOMES AND SAFETY OF PATIENTS UNDERGOING ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY COMBINING A SINGLE-USE CHOLANGIOSCOPE AND SINGLE-USE DUODENOSCOPE

11. MULTICENTER RETROSPECTIVE INTERNATIONAL STUDY TO EVALUATE OUTCOMES AND SAFETY OF PATIENTS UNDERGOING ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY COMBINING A SINGLE-USE CHOLANGIOSCOPE AND SINGLE-USE DUODENOSCOPE

16. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

18. Evaluation of biochemical and antioxidant properties of crude extracts from the Indian cattle leech Poecilobdella granulosa.

25. Gli oli essenziali di Monarda fistulosa e Monarda didyma inibiscono l’infettività dei virus Herpes simplex I e II in vitro

26. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

27. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

28. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

39. Dysplasia severity is associated with poor quality of life in patients with Barrett's esophagus referred for endoscopic eradication therapy

40. Platelet inhibition with ticagrelor 60 mg versus 90 mg twice daily in the PEGASUS-TIMI 54 trial

41. Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

43. Poster Session 2 : Monday 4 May 2015, 08

44. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

46. Poster Session 2: Monday 4 May 2015, 08:00-18:00 * Room: Poster Area

50. Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction

Catalog

Books, media, physical & digital resources